Search Results
Oct 25, 2025, 11:00 ET BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
Phase 3 Trials [abstract]. ACR 2025. #2129566. Rudwaleit M. Long-Term Uveitis Rates with Bimekizumab Treatment Across Pooled Phase 2b and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update [abstract]. ACR 2025. #2129301.
More news about: UCB
Oct 24, 2025, 08:34 ET Monstrous $250,000 Prize Pool Awaits This Spooky Season in ACR Poker's Halloween Special Mystery Bounty Tournament
to another level, especially with the added chance to win WSOP Paradise packages," said ACR Pro Chris Moneymaker. For players seeking more thrilling bounty action this Halloween season, ACR Poker is also running its flagship
More news about: ACR
Oct 24, 2025, 08:00 ET Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases
vivo therapies across a broad range of autoimmune and oncology indications, today announced an upcoming presentation at the American College of Rheumatology (ACR) Annual Meeting being held October 24-29, 2025, in Chicago, Illinois. This dataset is a broader update on Orna's lead program, ORN-252, as it continues
More news about: Orna Therapeutics
Oct 24, 2025, 07:29 ET Sobi showcases new data across rare inflammatory conditions at ACR 2025
treatments for patients with rare disease, will be presenting new data across its immunology portfolio at the annual American College of Rheumatology (ACR) Convergence 2025 meeting in Chicago, October 24-29. Sobi is presenting a total of 15 scientific abstracts, with six oral presentations featuring new
More news about: Swedish Orphan Biovitrum AB
Oct 23, 2025, 10:29 ET Protai Showcases Breakthroughs in Structural-Proteomics & AI Driven Drug Discovery at October Global Conferences
KAT6A degrader designed through Protai's AIMS™ platform. Protai will also be participating in ACR Convergence 2025, held at the McCormick Place Convention Center in Chicago, Illinois, as part of its strategic expansion into the Immunology
More news about: Protai
Oct 21, 2025, 11:00 ET Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025
ACR Convergence 2025 (October 24-29, Chicago), the annual meeting of the American College of Rheumatology, to demonstrate how its unique impact across
More news about: Lupus Research Alliance
Oct 21, 2025, 10:00 ET Lupus Foundation of America Research Showcased at 2025 American College of Rheumatology Annual Meeting
Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in Chicago, IL, taking place October 24-29. The presented research will spotlight bold efforts to broaden representation in
More news about: Lupus Foundation of America, Inc.
Oct 20, 2025, 08:30 ET AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases
C-CAR168 in patients with refractory autoimmune diseases will be presented as a late-breaking poster presentation at American College of Rheumatology (ACR) Convergence 2025, being held October 24-29, 2025, at McCormick Place in Chicago, Illinois. C-CAR168 is an autologous anti-CD20/BCMA bispecific Chimeric
More news about: AbelZeta Pharma, Inc.
Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
patient populations, including in patients with prior non-response to advanced therapies.21-23 Key measures of efficacy evaluated include ACR responses, Disease Activity Score (DAS28-CRP), patient-reported outcomes and inhibition of radiographic progression. More information on these trials
More news about: AbbVie
Oct 16, 2025, 09:00 ET Volpara Earns ACR® Learning Network Vendor Partner Designation
American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Volpara Health partnered with one of the latest graduates of the ACR ImPower Program Mammography
More news about: Volpara Health
Oct 15, 2025, 16:15 ET ACRES Commercial Realty Corp. to Report Results for Third Quarter 2025
UNIONDALE, N.Y., Oct. 15, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that it will release its results for the third quarter 2025, on Wednesday, October 29, 2025, after the market closes.
More news about: ACRES Commercial Realty Corp.
Oct 14, 2025, 09:00 ET Mount Sinai, Densitas and ACR ImPower Program Collaboration Increases the Quality of Mammography Positioning by 33%
Oct. 14, 2025 /PRNewswire/ - Densitas® has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Through the ACR ImPower Mammography Positioning Improvement Collaborative, Densitas and the Mount Sinai Health System worked side-by-side
More news about: Densitas Inc.
Oct 14, 2025, 01:54 ET 2025 ACR摘要公布！泰它西普治療干燥綜合征中國Ⅲ期臨床研究數據振奮
View original content to download multimedia:https://www.prnewswire.com/apac/zh/news-releases/2025-acr-302582974.html SOURCE 榮昌生物製藥（煙台）股份有限公司
More news about: 榮昌生物製藥（煙台）股份有限公司
Oct 14, 2025, 01:40 ET 2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China
In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League Against Rheumatism) Sjögren's Syndrome Disease
More news about: RemeGen Co., Ltd
Oct 13, 2025, 08:56 ET ACR Poker Introduces Brand-new Blitz Beast Rake Race With $30,000 In Weekly Prizes Up for Grabs
Poker players that same energy and competitive edge," said ACR Pro Chris Moneymaker. "With both leaderboards running, there's double the races, double the chances to win, and over half a million dollars in prizes every month. I love that ACR is giving players more variety, more fun, and now even more
More news about: ACR Poker
Oct 08, 2025, 09:11 ET Raising the Bar in Community Cancer Care: Florida Cancer Specialists & Research Institute Radiation Oncology Sites Earn ACR Accreditation
to relieve a cancer patient's symptoms. The ACR is the nation's oldest and most widely accepted radiation oncology accrediting body, with over 700 accredited sites, and 30 years of accreditation experience. The ACR gold seal of accreditation represents the highest level of quality
More news about: Florida Cancer Specialists & Research Institute
Oct 07, 2025, 08:33 ET Over 540 Seats Up for Grabs in Venom Fever Satellite Extravaganza at ACR Poker
ACRPoker.eu. About ACR PokerFormerly known as Americas Cardroom, ACR Poker joined the Winning Poker Network in 2011. The Winning Poker Network has been dealing cards since 2001 and continues
More news about: ACR Poker
Oct 03, 2025, 08:43 ET New $2,650 Mini Phil's Thrill Tourney Added to ACR Poker's High-Stakes Schedule
ACR Pro Chris Moneymaker, who claimed the crown and the $165,100 top prize in the September 14th event. Moneymaker said: "Taking down the biggest weekly tournament on ACR was just awesome. The mix of competition, atmosphere,
More news about: ACR
Oct 03, 2025, 08:37 ET Dual Venom PKO Tournaments Return to ACR Poker Bringing $6.5 Million in Guaranteed Prize Pools This October
the action for less, ACR Poker has an extravaganza of Venom Fever satellites for pennies on the dollar or even for free. There are hundreds of seats up for grabs through Direct Satellites and Mega Satellites to both Venoms. Over its past nine editions, ACR Poker's Venom NLH PKO
More news about: ACR
Oct 02, 2025, 08:42 ET ACR Poker Offers Players a Poker-Inspired Take on a Classic Favorite With the Launch of Plinko Poker
ACRPoker.eu. About ACR PokerFormerly known as Americas Cardroom, ACR Poker joined the Winning Poker Network in 2011. The Winning Poker Network has been dealing cards since 2001 and continues
More news about: ACR Poker
Oct 01, 2025, 08:00 ET RheumaGen Announces Oral Presentation on HLA Gene-Editing Preclinical Data for Lead Autoimmune Disease Program at ACR Convergence 2025
announced that a human leukocyte antigen (HLA) gene-editing abstract has been selected for oral presentation at the American College of Rheumatology (ACR) Convergence 2025, taking place October 24-29, 2025, in Chicago.
More news about: RheumaGen, Inc.
Sep 30, 2025, 08:33 ET ACR Poker to Award 72 WSOP Paradise Packages for Record-Breaking $60 Million Guaranteed Super Main Event
I took a chance on an $86 satellite, I never imagined it would turn into a world title," said former WSOP Main Event Champ and current ACR Pro Chris Moneymaker, "ACR Poker is giving everyday players that same chance to turn a small buy-in into a dream trip to paradise, and maybe even make history in
More news about: ACR Poker
Sep 29, 2025, 08:00 ET U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
response of ACR20 at Week 24.15 DISCOVER-2 was a Phase 3, multicenter, randomized, double-blind study evaluating the efficacy and safety of TREMFYA® administered by subcutaneous injection in biologic-naïve patients with active PsA. The primary endpoint was response of ACR20 at Week
More news about: Johnson & Johnson
Sep 24, 2025, 09:00 ET Alley Cat Rescue Urges Worldwide Spay/Neuter to Stop Suffering of Millions of Stray Cats for World Animal Day
2025 /PRNewswire/ -- With an estimated 400 million stray cats living on streets around the world, animal welfare organization Alley Cat Rescue (ACR) is calling for urgent global action on World Animal Day. Their message - spay and neuter your cats and, if you can, help fix at least one community
More news about: Alley Cat Rescue, Inc.
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
that it will release the latest preclinical data of ATG-201 (CD19 x CD3 TCE) in Poster Presentations at the 2025 American College of Rheumatology (ACR) Annual Meeting, taking place from October 24th to October 29th in Chicago, IL,
More news about: Antengene Corporation Limited